Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butrans in Osteoarthritis of the Hip or Knee
NCT00314652Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- Jun 1999
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Buprenorphine transdermal system with Placebo transdermal system (2 arms). Primary endpoints: Percentage of patients who were treated successfully for pain management at 28 days and Percentage of patients who failed treatment at 28 days. Started Jun 1999; status: completed.
02
Drugs
buprenorphine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00314652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314652.